Primary care doctors surveyed by the Medical Group Management Association say nearly 6% of their compensation was pegged to quality metrics in 2013, up from 3% in 2012.
Part of the drive to a value-based healthcare delivery system will be gearing physician compensation to value-based metrics such as quality and customer service, according to the Medical Group Management Association.
"This is going to be a gradual shift. … It will be a trend that we will see evolve," said Todd Evenson, VP of data solutions and consulting services at the Englewood, CO-based organization. "We're on the cusp of this information being available."
MGMA has been conducting an annual physician compensation survey for three decades. Beginning in 2012, the MGMA began collecting data on physicians who reported having a portion of their compensation linked to a pair of value-based metrics: quality and customer satisfaction.
Read the full story here: http://bit.ly/1kLvEsZ
Source: Health Leaders Media
Dr Terrance Mayes and Dr Loretta Erhunmwunsee Discuss Leadership Roles for NCCN Forum on Equity
January 31st 2023Terrance Mayes, EdD, and Loretta Erhunmwunsee, MD, FACS, discuss their new roles as chair and vice-chair, respectively, of the National Comprehensive Cancer Network’s (NCCN) new Diversity, Equity, & Inclusion (DEI) Directors Forum.
Read More
Promoting Health Equity and Resiliency in Trauma-Affected Communities
January 31st 2023On this episode of Managed Care Cast, we speak with Reverend Paul Abernathy, CEO of the Neighborhood Resilience Project and board member of UPMC for You, who discusses his experiences in promoting health and resiliency in trauma-affected communities, as well as challenges related to access and accessibility of care and medical mistrust.
Listen
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
First Humira Biosimilar, Amjevita, Launches in the United States
January 31st 2023The first of at least 8 adalimumab biosimilars has finally launched in the United States after being kept off the market for years due to settlement agreements with the maker of the reference product, Humira.
Read More
2 Clarke Drive
Cranbury, NJ 08512